The science of digital phenotyping is multidisciplinary. Digital phenotyping relies on users continued willingness to allow access to multiple data streams, ranging from on-device sensors to third-party social media, that provide insights into their everyday activity, both during development and thereafter. The promise of digital phenotyping is that this objective measure takes place in the context of a patient's lived experience, reflecting how he or she performs in his or her environment rather than in our clinic. As a clinical tool, digital phenotyping is currently being developed. This is the time for patients, families, providers, and researchers to determine the balance between clinical value and public trust in digital phenotyping.
Title : Precision Pharmacotherapy in the Treatment of Epilepsy - Use of Antiseizure Medications and Therapeutic Blood Level Monitoring
Roy Gary Beran, University of New South Wales, Australia
Title : When something comes on time, it is education, if too late, it is therapy. Health or disease - It is our choice
Ewa Danuta Bialek, Institute of Psychosynthesis, Poland
Title : Antibody-Proteases as translational tools of the newest generation to be applied for biodesign and bioengineering to get Precision and Personalized healthcare services Re-armed
Sergey Suchkov, The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
Title : Exposome for precision medicine
Styliani Geronikolou, University Research Institute of Maternal and Child health & Precision Medicine, Greece
Title : Precision Diagnostics and Medical Devices: Innovative Imaging Technologies for Lung Cancer Screening in Large Populations
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Use of indocyanine green fluorescence imaging in the extrahepatic biliary tract surgery
Orestis Ioannidis, Aristotle University of Thessaloniki, Greece